Authors: Erhardtsen, E Nilsson, P Johannessen, M Thomsen, MS

Citation: E. Erhardtsen et al., Pharmacokinetics and safety of FFR-rFVIIa after single doses in healthy subjects, J CLIN PHAR, 41(8), 2001, pp. 880-885

Authors: Hedner, U Erhardtsen, E

Citation: U. Hedner et E. Erhardtsen, Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI, ANN MED, 32, 2000, pp. 68-72

Authors: Erhardtsen, E

Citation: E. Erhardtsen, Pharmacokinetics of recombinant activated factor VII (rFVIIa), SEM THROMB, 26(4), 2000, pp. 385-391

Authors: Holm, P Andersen, HL Andersen, MR Erhardtsen, E Stender, S

Citation: P. Holm et al., The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium - A time course study in cholesterol-clamped rabbits, CIRCULATION, 100(16), 1999, pp. 1727-1733

Authors: Erhardtsen, E Nony, P Dechavanne, M Ffrench, P Boissel, JP Hedner, U

Citation: E. Erhardtsen et al., The effect of recombinant factor VIIa (NovoSeven (TM)) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0, BL COAG FIB, 9(8), 1998, pp. 741-748